Trial Profile
Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SILIUS
- 25 Jan 2020 Results presented at the 2020 Gastrointestinal Cancers Symposium
- 22 Mar 2017 Status changed from recruiting to completed.
- 17 Apr 2016 Primary endpoint (overall survival) has not been met, according to Results presented at The International Liver Congress 2016.